The pharmaceutical industry relies on a vast array of specialized chemical intermediates to develop effective treatments. Dorzolamide, identified by CAS 120279-96-1, is a significant organic intermediate, particularly crucial for the development of ophthalmic medications aimed at managing conditions like glaucoma. Its specific chemical structure and properties make it an indispensable component in these advanced formulations.

As a white or off-white powder, Dorzolamide is characterized by its high purity, typically assaying at a minimum of 99.5%. This level of purity is critical for ophthalmic applications where patient safety and drug efficacy are paramount. Impurities, even in trace amounts, could potentially cause adverse reactions or reduce the effectiveness of the final ophthalmic solution. Therefore, R&D scientists and formulation specialists must source Dorzolamide from manufacturers who adhere to stringent quality controls.

The chemical itself functions by inhibiting carbonic anhydrase, an enzyme found in the eye. This inhibition leads to a reduction in the production of aqueous humor, thereby lowering intraocular pressure. The precise molecular structure of Dorzolamide, with its formula C10H16N2O4S3 and molecular weight of 324.44, is key to its pharmacological activity. When you buy Dorzolamide for these applications, it's vital to ensure it meets pharmacopoeia standards such as USP, BP, EP, and FCC.

Procurement managers seeking to buy Dorzolamide can find reliable sources among Chinese manufacturers. These suppliers often offer the combination of high-quality products, including adherence to GMP and SGS certifications, along with competitive pricing. Direct engagement with these suppliers allows for clear communication regarding product specifications, packaging (e.g., 25kg/drum), and delivery timelines. Ensuring a stable supply of this key intermediate is vital for continuous production runs of ophthalmic drugs.

In conclusion, Dorzolamide CAS 120279-96-1 is a cornerstone intermediate for ophthalmic drug development. Its high purity and specific biochemical function make it a critical ingredient. Pharmaceutical companies should prioritize sourcing this compound from reputable manufacturers and suppliers who can guarantee quality and provide consistent supply, supporting the development of vital treatments for eye conditions.